|
|
Volumn 95, Issue 17, 2003, Pages 1268-1269
|
|
More states mandate coverage of clinical trial costs, but does it make a difference?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER RESEARCH;
CANCER THERAPY;
CLINICAL RESEARCH;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
HUMAN;
INFORMATION PROCESSING;
LAW;
MANAGED CARE ORGANIZATION;
MEDICAL SOCIETY;
NOTE;
PATIENT SELECTION;
PRIORITY JOURNAL;
REIMBURSEMENT;
UNITED STATES;
ARTICLE;
ECONOMICS;
HEALTH CARE COST;
HEALTH INSURANCE;
INSURANCE;
LEGAL ASPECT;
NEOPLASM;
STATISTICS;
CALIFORNIA;
CLINICAL TRIALS;
HEALTH CARE COSTS;
HUMANS;
INSURANCE COVERAGE;
INSURANCE, HEALTH;
NEOPLASMS;
RHODE ISLAND;
UNITED STATES;
|
|
EID: 0041329903
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/95.17.1268 Document Type: Note |
|
Times cited : (9)
|
|
References (0)
|